N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide

N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide is a synthetic small molecule with the molecular formula C19H28N4O2 and a molecular weight of approximately 344.5 g/mol[3][8]. It is classified as an experimental compound and has not been approved for clinical use in any jurisdiction[2][3][4]. The compound is structurally related to peptidomimetic inhibitors, but there are no published indications, clinical trials, or detailed pharmacological data available for this molecule. Its mechanism of action and therapeutic targets have not been established in the literature or major drug databases as of June 2025[2][3][4].

Other names

(2S)-N-[(4-carbamimidoylphenyl)methyl]-1-(4-methylpentanoyl)pyrrolidine-2-carboxamide(2S)-N-((4-carbamimidoylphenyl)methyl)-1-(4-methylpentanoyl)pyrrolidine-2-carboxamide